(C77) Secondary and unspecified malignant neoplasm of lymph nodes

More details coming soon

Icon
796 389 in individuals diagnosis secondary and unspecified malignant neoplasm of lymph nodes confirmed
Icon
38 714 deaths with diagnosis secondary and unspecified malignant neoplasm of lymph nodes
Icon
5% mortality rate associated with the disease secondary and unspecified malignant neoplasm of lymph nodes

Diagnosis secondary and unspecified malignant neoplasm of lymph nodes is diagnosed Men are 16.88% more likely than Women

465 416

Men receive the diagnosis secondary and unspecified malignant neoplasm of lymph nodes

27 736 (6.0 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
330 973

Women receive the diagnosis secondary and unspecified malignant neoplasm of lymph nodes

10 978 (3.3 %)

Died from this diagnosis.

Risk Group for the Disease secondary and unspecified malignant neoplasm of lymph nodes - Men and Women aged 60-64

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 5-14
Icon
In Women diagnosis is most often set at age 0-5, 15-95+

Disease Features secondary and unspecified malignant neoplasm of lymph nodes

Icon
Absence or low individual and public risk
Icon

Secondary and unspecified malignant neoplasm of lymph nodes - what does this mean

Secondary and unspecified malignant neoplasm of lymph nodes is a type of cancer that occurs when abnormal cells form in the lymph nodes. these cells can then spread to other parts of the body, leading to further complications. treatment typically involves surgery, radiation, and/or chemotherapy.

What happens during the disease - secondary and unspecified malignant neoplasm of lymph nodes

Secondary and unspecified malignant neoplasm of lymph nodes is a type of cancer that occurs when abnormal cells in a lymph node divide and grow uncontrollably. these abnormal cells can spread from their original location to other parts of the body. risk factors for this cancer include a weakened immune system, exposure to certain viruses, and certain genetic conditions.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete physical examination
  • Laboratory tests (blood tests, urinalysis, etc.)
  • Imaging studies (X-ray, CT scan, MRI, etc.)
  • Biopsy of the affected lymph node
  • Flow cytometry
  • Immunohistochemistry
  • Cytogenetic analysis
  • Molecular testing

Treatment and Medical Assistance

Main goal of the treatment: To reduce the size of the tumor and prevent it from spreading.
  • Perform biopsy to confirm the diagnosis
  • Administer chemotherapy to reduce the size of the tumor
  • Examine the patient for any signs of metastasis
  • Perform radiation therapy to target any remaining cancer cells
  • Monitor the patient's progress to ensure the cancer is not spreading
  • Prescribe medications to help manage any side effects of treatment
  • Provide emotional and psychological support to the patient
Icon
14 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Secondary and unspecified malignant neoplasm of lymph nodes - Prevention

The best way to prevent secondary and unspecified malignant neoplasm of lymph nodes is to reduce exposure to environmental carcinogens, maintain a healthy weight, exercise regularly, and practice safe sex. additionally, individuals should get regular check-ups and screenings for early detection and treatment.

Specified forms of the disease

(C13.0) Malignant neoplasm: Postcricoid region
(C13.1) Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect
(C13.2) Malignant neoplasm: Posterior wall of hypopharynx
(C13.8) Malignant neoplasm: Overlapping lesion of hypopharynx
(C13.9) Malignant neoplasm: Hypopharynx, unspecified